CVS Health Corporation's (CVS) growth in the third quarter of 2024 is backed by strong digital engagement and enhanced capabilities. Additionally, the company’s progress with the 2025 roadmap is encouraging. However, a dull macroeconomic scenario and fierce competition may restrict CVS Health’s growth potential.In the past year, this Zacks Rank #3 (Hold) company’s shares have lost 42.6% compared with the industry’s 47.9% decline. The S&P 500 composite rose 27.8% during the same timeframe.The leading retail ...